ziprasidone has been researched along with Alzheimer Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baralatei, FT; Lauterbach, EC | 1 |
Strawn, JR; Tambyraja, R | 1 |
2 other study(ies) available for ziprasidone and Alzheimer Disease
Article | Year |
---|---|
Switching to duloxetine remits ziprasidone - associated urinary incontinence and improves neuropsychiatric behavior in dementia: possible relationship of incontinence to 5HT2 receptor blockade.
Topics: Aged, 80 and over; Alzheimer Disease; Dementia, Vascular; Duloxetine Hydrochloride; Humans; Male; Parkinsonian Disorders; Piperazines; Receptors, Serotonin, 5-HT2; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Thiazoles; Thiophenes; Urinary Incontinence | 2009 |
Third degree heart block following intramuscular ziprasidone.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Bradycardia; Cardiopulmonary Resuscitation; Dementia, Vascular; Dose-Response Relationship, Drug; Female; Heart Block; Hospitalization; Humans; Injections, Intramuscular; Long QT Syndrome; Piperazines; Schizophrenia, Paranoid; Thiazoles | 2011 |